基质和抗生素识别的结构基础由Helicobacter pylori的isoleucyl-tRNA合成酶
Xiaobao Chen1, Yu Guo2,3,4,5, Jiawen Shi1
1Institute of Geriatrics, Affiliated Nantong Hospital of Shanghai University, Sixth People's Hospital of Nantong, Shanghai Engineering Research Center of Organ Repair, School of Medicine, Shanghai University, 500 Yonghe Road, Nantong, China.
对Helicobacter pylori isoleucyl-tRNA合成酶 (HpIleRS) 的结构洞察力揭示了针对H. pylori感染的抑制剂设计的机制. 了解HPIleRS结构有助于开发针对这一全球健康问题的向治疗方法.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 微生物学 微生物学
背景情况:
- 杆菌感染影响全球一半以上的人口,需要新的治疗策略.
- 药理学标的结构性阐明是设计抗细菌感染的有效抑制剂的关键.
研究的目的:
- 为了确定不同状态的H. pylori异构素-tRNA合成酶 (HpIleRS) 的晶体结构.
- 阐明基质识别和mupirocin抑制HpIleRS.的机制.
- 研究Asp641在HPIleRS功能中的潜在调节作用.
主要方法:
- 采用X射线晶体学,获得HpIleRS.的高分辨率结构.
- 进行生物化学分析以研究基质结合和酶动力学.
- 在apo-HpIleRS及其与基质和抑制剂的复合物之间进行了结构比较.
主要成果:
- 确定了阿波-HpIleRS及其与Ile,Ile-AMP,Val,Val-AMP和mupirocin复合物的晶体结构.
- 获得了关于基质特异性和HpIleRS识别的详细见解.
- 研究了mupirocin抑制的机制和Asp641的潜在调节作用.
结论:
- 确定的结构为设计针对H. pylori的向抑制剂提供了基础.
- 了解HPIleRS结构和抑制机制可以促进新抗H. pylori药物的开发.
- 这项研究为通过新的药理干预来对抗H. pylori感染提供了有希望的途径.
更多相关视频
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
06:40Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
相关概念视频
tRNA Activation
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Improving Translational Accuracy
